Dabigatran
- Generic Name
- Dabigatran
- Brand Names
- Dabigatran Etexilate Leon Farma, Dabigatran Etexilate Accord, Pradaxa
- Drug Type
- Small Molecule
- Chemical Formula
- C25H25N7O3
- CAS Number
- 211914-51-1
- Unique Ingredient Identifier
- I0VM4M70GC
- Background
Dabigatran is the active form of the orally bioavailable prodrug dabigatran etexilate.
D-dimer In Patients With atRial Fibrillation rEceiving antiCoagulation Therapy
- Conditions
- Strokes ThromboticAtrial Fibrillation
- Interventions
- First Posted Date
- 2017-09-12
- Last Posted Date
- 2017-09-12
- Lead Sponsor
- Wuhan Asia Heart Hospital
- Target Recruit Count
- 1194
- Registration Number
- NCT03280641
- Locations
- 🇨🇳
WAHH, Wuhan, Hubei, China
This Study Uses the SITS Registry to Find Out When Patients With a Heart Rhythm Disorder (Atrial Fibrillation) Start Treatment With Dabigatran After They Had a Stroke
- First Posted Date
- 2017-08-23
- Last Posted Date
- 2020-07-09
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 1489
- Registration Number
- NCT03258645
- Locations
- 🇸🇪
SITS International (c/o Karolinska University Hospital), Stockholm, Sweden
Medical Need of OAC Reversal
- Conditions
- Atrial Fibrillation
- Interventions
- First Posted Date
- 2017-08-18
- Last Posted Date
- 2019-03-04
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 53969
- Registration Number
- NCT03254147
- Locations
- 🇯🇵
Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan
Comparative Effectiveness and Safety Between Warfarin and Dabigatran
- First Posted Date
- 2017-08-18
- Last Posted Date
- 2019-07-09
- Lead Sponsor
- Boehringer Ingelheim
- Target Recruit Count
- 22490
- Registration Number
- NCT03254134
- Locations
- 🇯🇵
Nippon Boehringer Ingelheim Co., Ltd., Tokyo, Japan
A Real-World Comparison of Safety and Effectiveness of Novel Oral Anti-Coagulant (NOAC) Naïve and Warfarin Naïve Non-Valvular Atrial Fibrillation (NVAF) Patients With Medicare Advantage Coverage
- Conditions
- Atrial Fibrillation
- Interventions
- First Posted Date
- 2017-06-16
- Last Posted Date
- 2019-01-30
- Lead Sponsor
- Bristol-Myers Squibb
- Target Recruit Count
- 36000
- Registration Number
- NCT03189069
Tooth Extraction in Patients With Atrial Fibrillation in Use of New Oral Anticoagulants
- Conditions
- Atrial FibrillationPeriodontal DiseaseHemorrhage
- Interventions
- First Posted Date
- 2017-06-08
- Last Posted Date
- 2022-06-15
- Lead Sponsor
- University of Sao Paulo General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT03181386
- Locations
- 🇧🇷
Heart Institute of Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil
Start or STop Anticoagulants Randomised Trial (SoSTART)
- Conditions
- Subdural HematomaIntraventricular HemorrhageIntracranial HemorrhagesIntracranial Hemorrhage, HypertensiveSubarachnoid HemorrhageAtrial FibrillationMicrohaemorrhageAtrial FlutterSmall Vessel Cerebrovascular Disease
- Interventions
- First Posted Date
- 2017-05-15
- Last Posted Date
- 2022-04-08
- Lead Sponsor
- University of Edinburgh
- Target Recruit Count
- 203
- Registration Number
- NCT03153150
- Locations
- 🇬🇧
Frimley Park Hospital, Frimley, United Kingdom
🇬🇧Gloucestershire Royal Hospital, Gloucester, United Kingdom
🇬🇧Pinderfields Hospital, Wakefield, United Kingdom
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Atrial Fibrillation
- Conditions
- Atrial FlutterAtrial Fibrillation
- Interventions
- First Posted Date
- 2017-04-26
- Last Posted Date
- 2025-05-18
- Lead Sponsor
- Herlev and Gentofte Hospital
- Target Recruit Count
- 11000
- Registration Number
- NCT03129490
- Locations
- 🇩🇰
Hjerteklinik Østerbro I/S, Copenhagen Ø, Denmark
🇩🇰Hjerteklinik Nordjylland, Aalborg, Denmark
🇩🇰Aarhus University Hospital, Aarhus, Denmark
The Danish Non-vitamin K Antagonist Oral Anticoagulation Study in Patients With Venous Thromboembolism (DANNOAC-VTE)
- Conditions
- Pulmonary EmbolismDeep Vein Thrombosis
- Interventions
- First Posted Date
- 2017-04-26
- Last Posted Date
- 2025-05-15
- Lead Sponsor
- Herlev and Gentofte Hospital
- Target Recruit Count
- 5000
- Registration Number
- NCT03129555
- Locations
- 🇩🇰
Aarhus University Hospital, Aarhus, Denmark
🇩🇰Bispebjerg Hospital, Copenhagen NV, Denmark
🇩🇰Amager Hospital, Copenhagen S, Denmark
Use of Direct Oral Anticoagulants in UK
- Conditions
- Stroke
- Interventions
- First Posted Date
- 2017-04-18
- Last Posted Date
- 2020-04-17
- Lead Sponsor
- Bayer
- Target Recruit Count
- 31336
- Registration Number
- NCT03119116
- Locations
- 🇬🇧
Many Locations, Multiple Locations, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.